Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ: ARCT )

27.49 -0.90 (-3.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 221,907
Open 28.62
Bid (Size) 27.48 (39)
Ask (Size) 27.52 (4)
Prev. Close 28.39
Today's Range 27.31 - 28.83
52wk Range 11.70 - 33.80
Shares Outstanding 26,562,951
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90
On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier. 
Via Investor's Business Daily
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency
From Arcturus Therapeutics Holdings Inc.
Via Business Wire

Performance

YTD
+64.61%
+64.61%
1 Month
-6.53%
-6.53%
3 Month
+86.50%
+86.50%
6 Month
+62.47%
+62.47%
1 Year
+60.48%
+60.48%

More News

Read More
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
Via Investor's Business Daily
Ionis Pharmaceuticals Stock Sees IBD RS Rating Climb To 79
Via Investor's Business Daily
Amicus Therapeutics Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark
Via Investor's Business Daily
Arcturus Therapeutics: Q1 Earnings Insights
Via Benzinga
Why Arcturus Therapeutics Stock Is Soaring Today
Via The Motley Fool
Arcturus Therapeutics's Return On Capital Employed Insights
Via Benzinga
Ultragenyx Pharm Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
Analyst's Vote of Confidence: Arcturus' COVID-19 Vaccine Efforts Set to Pay Off in Japan and Beyond
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
Unity Software, Tapestry, CIRCOR International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
S&P 500 Up 1%; Bluebird Bio Shares Plummet
Via Benzinga
Stocks Rise As Investors Bet On Bank Recovery
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Arcturus Therapeutics Ltd. (NASDAQ: ARCT) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Nasdaq Rises 1%; US Pending Home Sales Increase In February
Via Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On?
Via Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.